• ქართული
  • English
  • Roche, Spark again extend $4.3 billion takeover offer

    Roche Holding and Spark Therapeutics announced on Tuesday another extension of the Swiss drugmaker’s $4.3 billion takeover offer for the U.S. gene therapy specialist as regulatory reviews continue.

    Market Quotes by TradingView